Hepatobiliary Cancers | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Hepatobiliary Cancers

published 4 days ago by Dr Neil Love

Proceedings from a CME symposium held at the 2020 Gastrointestinal Cancers Symposium. Featuring perspectives from Dr Ghassan Abou-Alfa, Dr Anthony El-Khoueiry, Dr Richard S Finn, Professor Dr Peter R Galle and Dr Andrew X Zhu. Introduction (00:00) First-Line Systemic Therapy for Patients with Unresectable Hepatocellular Carcinoma (HCC) — Dr Finn (16:35) Available Data with and Patient Selection for Anti-angiogenic Therapy for Progressive Metastatic HCC — Dr Zhu (47:41) Published Data with and Appropriate Integration of Immune Checkpoint Inhibitors into the Care of Patients with Progressive Metastatic HCC — Dr El-Khoueiry (1:07:51) Novel Approaches Under Investigation for Advanced HCC — Prof Galle (1:23:35) Current and Future Management of Advanced Biliary Tract Cancers — Dr Abou-Alfa (1:42:48) CME information and select publications

more episodes from Research To Practice | Oncology Videos